Pam Belluck's article chronicles the inspiring journey of Amanda Sifford, a 58-year-old A.L.S. patient, who, after receiving the recently FDA-approved genetic therapy tofersen, experienced remarkable improvements in her breathing and overall condition, defying the typical progression of the disease and igniting hope for others affected by A.L.S. #ALS #Neurology #TreatmentInnovation #US #CA
www.nytimes.com
Tofersen, a New Treatment for A.L.S., Reverses Symptoms for Some
Pam Belluck spent time with an A. L. S. patient who is being treated with the new therapy in Miami.
Time was running out for Amanda Sifford, she and her doctors could tell.